|
MEAF6 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.873400E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.404000E-01 |
| Normal-vs-Stage2 |
2.536200E-01 |
| Normal-vs-Stage3 |
7.026000E-01 |
| Normal-vs-Stage4 |
6.053600E-01 |
| Stage1-vs-Stage2 |
4.861400E-01 |
| Stage1-vs-Stage3 |
8.974200E-01 |
| Stage1-vs-Stage4 |
9.247200E-01 |
| Stage2-vs-Stage3 |
4.947800E-01 |
| Stage2-vs-Stage4 |
7.377600E-01 |
| Stage3-vs-Stage4 |
8.418800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.455400E-01 |
| Normal-vs-AfricanAmerican |
3.600000E-01 |
| Normal-vs-Asian |
8.839000E-01 |
| Caucasian-vs-AfricanAmerican |
3.954000E-01 |
| Caucasian-vs-Asian |
9.983800E-01 |
| AfricanAmerican-vs-Asian |
7.519800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.587800E-01 |
| Normal-vs-Female |
1.744210E-01 |
| Male-vs-Female |
5.359700E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.983800E-01 |
| Normal-vs-Extreme_Weight |
3.830000E-01 |
| Normal-vs-Obese |
7.249200E-01 |
| Normal-vs-Extreme_Obese |
3.544400E-01 |
| Normal_Weight-vs-Extreme_Weight |
5.374000E-01 |
| Normal_Weight-vs-Obese |
7.972400E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.982200E-01 |
| Extreme_Weight-vs-Obese |
6.211800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.857600E-01 |
| Obese-vs-Extreme_Obese |
5.949800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.071000E-01 |
| Normal-vs-Age(41-60Yrs) |
5.662600E-01 |
| Normal-vs-Age(61-80Yrs) |
1.127970E-01 |
| Normal-vs-Age(81-100Yrs) |
9.972000E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.541600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.304100E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.836300E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.546480E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.496050E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.588400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
8.861200E-01 |
| Normal-VS-Type2 PRCC |
1.358370E-01 |
| Normal-VS-KIRP CIMP |
2.770600E-01 |
| Normal-VS-Unclassified PRCC |
9.612400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
9.933800E-02 |
| Type1 PRCC-VS-KIRP CIMP |
4.136200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
8.538000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.195600E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
1.273380E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.617800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.692200E-02 |
| Normal-vs-N1 |
6.546600E-01 |
| Normal-vs-N2 |
5.381800E-01 |
| N0-vs-N1 |
3.898000E-02 |
| N0-vs-N2 |
1.518640E-01 |
| N1-vs-N2 |
7.708000E-01 |
|
|
